Pharma & Biotech
Q BioMed's manufacturer of cancer bone pain drug Strontium-89 wins FDA clearance; shares rocket
The long-awaited approval of the IsoTherapeutics Group facility means the pain drug will soon be available to US patients and the rest of the world
Create your account: sign up and get ahead on news and events
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.